COOPER COS INC cut its annual profit forecast on Wednesday evening, sending shares down 15% in extended trading after third-quarter revenue missed Wall Street estimates. The medical device maker pointed to soft contact lens demand and lower United States channel inventory. The adjustment marks a sharp pivot for the California-based firm, which simultaneously concluded a strategic review of its surgical unit.

Board Retains Surgical Unit Following Review